...
首页> 外文期刊>Surgical Endoscopy >Clinical outcome of the laparoscopic surgery for stage II and III colorectal cancer.
【24h】

Clinical outcome of the laparoscopic surgery for stage II and III colorectal cancer.

机译:腹腔镜手术治疗II期和III期结直肠癌的临床结果。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Laparoscopic colorectal cancer surgery has become widely accepted recently. However, the oncological validity of this surgery has not yet been well analyzed, especially for advanced cancer. The aim of this study is to assess the clinical outcome of laparoscopic surgery for stage II/III colorectal cancer in our hospital. PATIENTS AND METHODS: Between June 1999 and August 2006, 321 patients underwent laparoscopic colorectal cancer surgery in our hospital; of those 121 cases whose pathological findings revealed stage II/III were included in this study. Among these cases, we assessed a short-term outcome and a medium-term outcome in terms of survival evaluation. RESULTS: The male:female ratio was 73:48, and mean age of patients was 62.4 years. Thirteen tumors were located in the cecum, 29 in the ascending colon, five in the transverse colon, one in the descending colon, 43 in the sigmoid colon, and 30 in the rectum. Average duration of operation was 184 minutes, and mean estimated blood loss was 53.5 ml. Five patients (4.1%) were converted to open procedures. No intraoperative complication was observed but eight complications (6.6%) occurred postoperatively. Forty-two cases were classified as stage II, 62 as stage IIIA /B, and 17 as stage IIIC. Five patients died of cancer relapse (4.1%), and 18 cases had recurrence of disease (14.9%), to date. No port-site recurrence was detected. Overall five-year survival was 95.7% in stage II, 84.1% in stage IIIA/B, 70.0% in stage IIIC. Meanwhile disease-free five-year survival was 75.6% in stage II, 80.1% in stage IIIA/B, and 66.8% in stage IIIC. No significant difference was observed between stages, in terms of either overall or disease-free survival. CONCLUSION: Although further evaluation is required, laparoscopic surgery for stage II/III colorectal cancer is safe and would be an oncologically adequate procedure.
机译:背景:腹腔镜结直肠癌手术最近已被广泛接受。但是,该手术的肿瘤学有效性尚未得到很好的分析,特别是对于晚期癌症。这项研究的目的是评估我院腹腔镜手术治疗II / III期大肠癌的临床效果。患者与方法:1999年6月至2006年8月,我院321例患者接受了腹腔镜结直肠癌手术。该研究包括了121例病理结果显示II / III期的病例。在这些案例中,我们根据生存评估评估了短期结果和中期结果。结果:男女比例为73:48,患者平均年龄为62.4岁。盲肠中有13个肿瘤,升结肠中有29个,横结肠中有5个,降结肠中有1个,乙状结肠中有43个,直肠中有30个。平均手术时间为184分钟,平均估计失血量为53.5 ml。五名患者(4.1%)被转为开放治疗。没有观察到术中并发症,但术后发生了8例并发症(6.6%)。 42例被分类为II期,62例被分类为IIIA / B期,17例被分类为IIIC期。迄今为止,有5例患者死于癌症复发(4.1%),18例疾病复发(14.9%)。未检测到端口站点重复发生。 II期的总体五年生存率为95.7%,IIIA / B期的为84.1%,IIIC期的为70.0%。同时,II期无病五年生存率为75.6%,IIIA / B期为80.1%,IIIC期为66.8%。在总体生存期或无病生存期方面,各阶段之间未观察到显着差异。结论:尽管需要进一步评估,但腹腔镜手术治疗II / III期结直肠癌是安全的,并且在肿瘤学上是适当的程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号